TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ultrasound Guided Arterial Puncture: a Prospective, Blinded, Randomised Controlled Trial.
Brief Summary: The main purpose of the study is to evaluate whether the routine use of ultrasound guided arterial puncture can increase the proportion of patients who only needs one puncture attempt in order to successfully extract enough blood to make an arterial blood gas analysis, when ultrasound guided arterial puncture is compared to conventional arterial puncture technique.


Options:
A: Arm Label: Ultrasound guided arterial puncture; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound guided arterial puncture | Arm Label: Conventional arterial puncture technique; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional arterial puncture technique | Intervention Type: PROCEDURE; Name: Ultrasound guided arterial puncture; Assigned to Arm(s): Ultrasound guided arterial puncture | Intervention Type: PROCEDURE; Name: Conventional arterial puncture technique; Assigned to Arm(s): Conventional arterial puncture technique
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Ultrasound; Type: EXPERIMENTAL; Interventions: Device: Real-time Ultrasound Guidance (Site-Rite 5 or 6 machine) | Intervention Type: DEVICE; Name: Real-time Ultrasound Guidance (Site-Rite 5 or 6 machine); Assigned to Arm(s): Ultrasound
C: Arm Label: Distal radial artery access; Type: EXPERIMENTAL; Interventions: Procedure: Distal radial artery access | Arm Label: Proximal radial artery access; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Proximal radial artery surgery | Intervention Type: PROCEDURE; Name: Distal radial artery access; Assigned to Arm(s): Distal radial artery access | Intervention Type: PROCEDURE; Name: Proximal radial artery surgery; Assigned to Arm(s): Proximal radial artery access
D: Arm Label: Ultrasound radial artery catheter; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound guided radial artery catheterization. | Arm Label: Palpation based artery catheterization; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Blind insertion of radial artery catheterization | Intervention Type: PROCEDURE; Name: Ultrasound guided radial artery catheterization.; Assigned to Arm(s): Ultrasound radial artery catheter | Intervention Type: PROCEDURE; Name: Blind insertion of radial artery catheterization; Assigned to Arm(s): Palpation based artery catheterization

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Large, International, Randomized, Placebo-controlled Trial to Assess the Impact of Dabigatran (a Direct Thrombin Inhibitor) and Omeprazole (a Proton-pump Inhibitor) in Patients Suffering Myocardial Injury After Noncardiac Surgery
Brief Summary: Patients who have myocardial injury after noncardiac surgery are at a higher risk of dying than those who do not. One in 10 patients with myocardial injury will die within 30 days of surgery. This risk of death exists up to one year after myocardial injury. There are currently no treatments or guidelines available for heart injury after surgery, but there is evidence that taking a blood-thinner can prevent some of the deaths, both in the short and long-term. The purpose of this trial is to test the effect of two drugs (dabigatran and omeprazole) that may prevent mortality, major cardiovascular complications and major upper gastrointestinal bleeding in patients who have had myocardial injury after noncardiac surgery.


Options:
A: Arm Label: A1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Apixaban | Arm Label: A2; Type: EXPERIMENTAL; Interventions: Drug: Apixaban | Arm Label: A3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: A4; Type: EXPERIMENTAL; Interventions: Drug: Apixaban | Intervention Type: DRUG; Name: Apixaban; Assigned to Arm(s): A1 | Intervention Type: DRUG; Name: Apixaban; Assigned to Arm(s): A2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A3 | Intervention Type: DRUG; Name: Apixaban; Assigned to Arm(s): A4
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Ticagrelor 90 mg | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Ticagrelor 60 mg | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Ticagrelor Placebo | Intervention Type: DRUG; Name: Ticagrelor 90 mg; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Ticagrelor 60 mg; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Ticagrelor Placebo; Assigned to Arm(s): 3
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: warfarin | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: apixaban | Intervention Type: DRUG; Name: warfarin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: apixaban; Assigned to Arm(s): 2
D: Arm Label: Dabigatran; Type: EXPERIMENTAL; Interventions: Drug: Dabigatran | Arm Label: Omeprazole; Type: EXPERIMENTAL; Interventions: Drug: Omeprazole | Arm Label: Placebo (dabigatran); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (for Dabigatran) | Arm Label: Placebo (omeprazole); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (for Omeprazole) | Intervention Type: DRUG; Name: Dabigatran; Assigned to Arm(s): Dabigatran | Intervention Type: DRUG; Name: Placebo (for Dabigatran); Assigned to Arm(s): Placebo (dabigatran) | Intervention Type: DRUG; Name: Omeprazole; Assigned to Arm(s): Omeprazole | Intervention Type: DRUG; Name: Placebo (for Omeprazole); Assigned to Arm(s): Placebo (omeprazole)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of Using Preconceptional Enoxaparin AND Low Dose Aspirin 81mg in Patient With Antiphospholipid Syndrome(APS)
Brief Summary: Preconceptional use of low molecular weight heparin (enoxaparin) and aspirin in patient with recurrent miscarriages with positive anti phospholipid antibodies increase the implantation rate and the duration of pregnancy with low complications to the mother and the baby.


Options:
A: Arm Label: ASA; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aspirin | Arm Label: Klexane; Type: ACTIVE_COMPARATOR; Interventions: Drug: Klexane | Arm Label: Aspirin and Enoxaparine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Klexane and ASA | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): ASA | Intervention Type: DRUG; Name: Klexane; Assigned to Arm(s): Klexane | Intervention Type: DRUG; Name: Klexane and ASA; Assigned to Arm(s): Aspirin and Enoxaparine
B: Arm Label: Aspirin; Type: EXPERIMENTAL; Interventions: Drug: Aspirin | Arm Label: Aspirin + heparin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aspirin, Drug: Heparin | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): Aspirin, Aspirin + heparin | Intervention Type: DRUG; Name: Heparin; Assigned to Arm(s): Aspirin + heparin
C: Arm Label: Group A(heparin group); Type: ACTIVE_COMPARATOR; Interventions: Drug: Heparin | Arm Label: Group B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Heparin; Assigned to Arm(s): Group A(heparin group)
D: Arm Label: Low molecular weight heparin; Type: N/A; Interventions: Drug: low molecular weight heparin (enoxeparine) | Intervention Type: DRUG; Name: low molecular weight heparin (enoxeparine); Assigned to Arm(s): Low molecular weight heparin

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of Using Preconceptional Enoxaparin AND Low Dose Aspirin 81mg in Patient With Antiphospholipid Syndrome(APS)
Brief Summary: Preconceptional use of low molecular weight heparin (enoxaparin) and aspirin in patient with recurrent miscarriages with positive anti phospholipid antibodies increase the implantation rate and the duration of pregnancy with low complications to the mother and the baby.


Options:
A: Arm Label: ASA; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aspirin | Arm Label: Klexane; Type: ACTIVE_COMPARATOR; Interventions: Drug: Klexane | Arm Label: Aspirin and Enoxaparine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Klexane and ASA | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): ASA | Intervention Type: DRUG; Name: Klexane; Assigned to Arm(s): Klexane | Intervention Type: DRUG; Name: Klexane and ASA; Assigned to Arm(s): Aspirin and Enoxaparine
B: Arm Label: Low molecular weight heparin; Type: N/A; Interventions: Drug: low molecular weight heparin (enoxeparine) | Intervention Type: DRUG; Name: low molecular weight heparin (enoxeparine); Assigned to Arm(s): Low molecular weight heparin
C: Arm Label: enoxaparin 40 mg plus low dose aspirin; Type: EXPERIMENTAL; Interventions: Drug: enoxaparin 40mg plus low dose aspirin | Arm Label: Heparin calcium 5,000 U twice daily plus low dose aspirin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Heparin calcium5,000 U twice daily plus low dose aspirin | Intervention Type: DRUG; Name: enoxaparin 40mg plus low dose aspirin; Assigned to Arm(s): enoxaparin 40 mg plus low dose aspirin | Intervention Type: DRUG; Name: Heparin calcium5,000 U twice daily plus low dose aspirin; Assigned to Arm(s): Heparin calcium 5,000 U twice daily plus low dose aspirin
D: Arm Label: Enoxaparin Once Daily; Type: ACTIVE_COMPARATOR; Interventions: Drug: Enoxaparin | Arm Label: Enoxaparin Twice Daily; Type: ACTIVE_COMPARATOR; Interventions: Drug: Enoxaparin | Intervention Type: DRUG; Name: Enoxaparin; Assigned to Arm(s): Enoxaparin Once Daily, Enoxaparin Twice Daily

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of Using Preconceptional Enoxaparin AND Low Dose Aspirin 81mg in Patient With Antiphospholipid Syndrome(APS)
Brief Summary: Preconceptional use of low molecular weight heparin (enoxaparin) and aspirin in patient with recurrent miscarriages with positive anti phospholipid antibodies increase the implantation rate and the duration of pregnancy with low complications to the mother and the baby.


Options:
A: Intervention Type: DRUG; Name: Low dose steroids; Assigned to Arm(s): N/A
B: Arm Label: Low molecular weight heparin; Type: N/A; Interventions: Drug: low molecular weight heparin (enoxeparine) | Intervention Type: DRUG; Name: low molecular weight heparin (enoxeparine); Assigned to Arm(s): Low molecular weight heparin
C: Arm Label: Rivaroxaban; Type: EXPERIMENTAL; Interventions: Drug: Experimental: Rivaroxaban | Arm Label: Warfarin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Experimental: Rivaroxaban | Intervention Type: DRUG; Name: Experimental: Rivaroxaban; Assigned to Arm(s): Rivaroxaban, Warfarin
D: Arm Label: ASA; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aspirin | Arm Label: Klexane; Type: ACTIVE_COMPARATOR; Interventions: Drug: Klexane | Arm Label: Aspirin and Enoxaparine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Klexane and ASA | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): ASA | Intervention Type: DRUG; Name: Klexane; Assigned to Arm(s): Klexane | Intervention Type: DRUG; Name: Klexane and ASA; Assigned to Arm(s): Aspirin and Enoxaparine

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of Using Preconceptional Enoxaparin AND Low Dose Aspirin 81mg in Patient With Antiphospholipid Syndrome(APS)
Brief Summary: Preconceptional use of low molecular weight heparin (enoxaparin) and aspirin in patient with recurrent miscarriages with positive anti phospholipid antibodies increase the implantation rate and the duration of pregnancy with low complications to the mother and the baby.


Options:
A: Intervention Type: DRUG; Name: Low dose steroids; Assigned to Arm(s): N/A
B: Arm Label: Group A(heparin group); Type: ACTIVE_COMPARATOR; Interventions: Drug: Heparin | Arm Label: Group B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Heparin; Assigned to Arm(s): Group A(heparin group)
C: Arm Label: enoxaparin 40 mg plus low dose aspirin; Type: EXPERIMENTAL; Interventions: Drug: enoxaparin 40mg plus low dose aspirin | Arm Label: Heparin calcium 5,000 U twice daily plus low dose aspirin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Heparin calcium5,000 U twice daily plus low dose aspirin | Intervention Type: DRUG; Name: enoxaparin 40mg plus low dose aspirin; Assigned to Arm(s): enoxaparin 40 mg plus low dose aspirin | Intervention Type: DRUG; Name: Heparin calcium5,000 U twice daily plus low dose aspirin; Assigned to Arm(s): Heparin calcium 5,000 U twice daily plus low dose aspirin
D: Arm Label: Low molecular weight heparin; Type: N/A; Interventions: Drug: low molecular weight heparin (enoxeparine) | Intervention Type: DRUG; Name: low molecular weight heparin (enoxeparine); Assigned to Arm(s): Low molecular weight heparin

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluating Violence Against Women Screening in Mexico
Brief Summary: The overall goal of this proposed study is to develop the state of knowledge in the area of gender-based violence and reproductive health by conducting a randomized controlled trial to improve the health care provider's capacity to screen for intimate partner violence and to mitigate associated risk among women health clinic patrons of reproductive age (ages18-44) with recent experiences of physical or sexual partner violence in Mexico City and its surrounding area.

The specific research objectives are as follows:

1. To increase mid-level health care providers' capacity to identify Intimate Partner Violence (IPV) and assist women with risk mitigation
2. Utilizing a randomized controlled trial, to assess the impact of an enhanced health care worker screening and counselling program on (a) past year severe IPV (sexual or physical), including severe IPV; (b) reproductive coercion (c) use of community-based resources and safety planning; and (d) quality of life; versus minimum standard of care
3. To qualitatively examine which programmatic components may serve as mechanisms for observed changes stated in the second objective
4. To synthesize study findings and a) create recommendations for clinic-based intervention programs to address IPV in low and middle income countries and b) disseminate information as reports, presentation, and peer-reviewed publications


Options:
A: Arm Label: Referral Card Only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Integrated Screening; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Screening | Intervention Type: BEHAVIORAL; Name: Integrated Screening; Assigned to Arm(s): Integrated Screening
B: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: The SHARE Project | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: The SHARE Project; Assigned to Arm(s): Intervention arm
C: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A
D: Arm Label: Brief Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Enhancement Therapy | Arm Label: Assessed Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: No Contact Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational Enhancement Therapy; Assigned to Arm(s): Brief Intervention Group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluating Violence Against Women Screening in Mexico
Brief Summary: The overall goal of this proposed study is to develop the state of knowledge in the area of gender-based violence and reproductive health by conducting a randomized controlled trial to improve the health care provider's capacity to screen for intimate partner violence and to mitigate associated risk among women health clinic patrons of reproductive age (ages18-44) with recent experiences of physical or sexual partner violence in Mexico City and its surrounding area.

The specific research objectives are as follows:

1. To increase mid-level health care providers' capacity to identify Intimate Partner Violence (IPV) and assist women with risk mitigation
2. Utilizing a randomized controlled trial, to assess the impact of an enhanced health care worker screening and counselling program on (a) past year severe IPV (sexual or physical), including severe IPV; (b) reproductive coercion (c) use of community-based resources and safety planning; and (d) quality of life; versus minimum standard of care
3. To qualitatively examine which programmatic components may serve as mechanisms for observed changes stated in the second objective
4. To synthesize study findings and a) create recommendations for clinic-based intervention programs to address IPV in low and middle income countries and b) disseminate information as reports, presentation, and peer-reviewed publications


Options:
A: Arm Label: Clinics trained in brief intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Family Planning-based Partner Violence Intervention | Arm Label: Control sites providing standard of care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Family Planning-based Partner Violence Intervention; Assigned to Arm(s): Clinics trained in brief intervention
B: Arm Label: Model Care (SEEK); Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced pediatric primary care | Arm Label: Standard pediatric primary care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard pediatric primary care | Intervention Type: BEHAVIORAL; Name: Enhanced pediatric primary care; Assigned to Arm(s): Model Care (SEEK) | Intervention Type: BEHAVIORAL; Name: Standard pediatric primary care; Assigned to Arm(s): Standard pediatric primary care
C: Arm Label: Enhanced NFP (NFP+); Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced NFP (NFP+) | Arm Label: NFP as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: NFP as usual | Intervention Type: BEHAVIORAL; Name: Enhanced NFP (NFP+); Assigned to Arm(s): Enhanced NFP (NFP+) | Intervention Type: BEHAVIORAL; Name: NFP as usual; Assigned to Arm(s): NFP as usual
D: Arm Label: Referral Card Only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Integrated Screening; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Screening | Intervention Type: BEHAVIORAL; Name: Integrated Screening; Assigned to Arm(s): Integrated Screening

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluating Violence Against Women Screening in Mexico
Brief Summary: The overall goal of this proposed study is to develop the state of knowledge in the area of gender-based violence and reproductive health by conducting a randomized controlled trial to improve the health care provider's capacity to screen for intimate partner violence and to mitigate associated risk among women health clinic patrons of reproductive age (ages18-44) with recent experiences of physical or sexual partner violence in Mexico City and its surrounding area.

The specific research objectives are as follows:

1. To increase mid-level health care providers' capacity to identify Intimate Partner Violence (IPV) and assist women with risk mitigation
2. Utilizing a randomized controlled trial, to assess the impact of an enhanced health care worker screening and counselling program on (a) past year severe IPV (sexual or physical), including severe IPV; (b) reproductive coercion (c) use of community-based resources and safety planning; and (d) quality of life; versus minimum standard of care
3. To qualitatively examine which programmatic components may serve as mechanisms for observed changes stated in the second objective
4. To synthesize study findings and a) create recommendations for clinic-based intervention programs to address IPV in low and middle income countries and b) disseminate information as reports, presentation, and peer-reviewed publications


Options:
A: Intervention Type: BEHAVIORAL; Name: Prompting (survey instrument/resources list) (behavior); Assigned to Arm(s): N/A
B: Arm Label: Referral Card Only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Integrated Screening; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Screening | Intervention Type: BEHAVIORAL; Name: Integrated Screening; Assigned to Arm(s): Integrated Screening
C: Arm Label: Clinics trained in brief intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Family Planning-based Partner Violence Intervention | Arm Label: Control sites providing standard of care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Family Planning-based Partner Violence Intervention; Assigned to Arm(s): Clinics trained in brief intervention
D: Arm Label: Model Care (SEEK); Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced pediatric primary care | Arm Label: Standard pediatric primary care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard pediatric primary care | Intervention Type: BEHAVIORAL; Name: Enhanced pediatric primary care; Assigned to Arm(s): Model Care (SEEK) | Intervention Type: BEHAVIORAL; Name: Standard pediatric primary care; Assigned to Arm(s): Standard pediatric primary care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly
Brief Summary: The primary objective is to examine the efficacy of 8-weeks of a locally developed brain-computer interface based system (BrainpalTM)intervention for improving attention and memory in normal elderly. We hypothesize that elderly who have completed the training program will have significant improvement in their attention and memory compared to the controls, based on the Repeatable Battery for the Assessment of Neuropsychological Status.


Options:
A: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Device: BrainPalTM | Arm Label: Wait-List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: BrainPalTM; Assigned to Arm(s): Intervention
B: Arm Label: LLM; Type: EXPERIMENTAL; Interventions: Other: LLM | Arm Label: PTC; Type: EXPERIMENTAL; Interventions: Other: FFA | Arm Label: CTC; Type: EXPERIMENTAL; Interventions: Other: Brain Fitness | Arm Label: Passive; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Active; Type: ACTIVE_COMPARATOR; Interventions: Other: VideoGrade | Intervention Type: OTHER; Name: LLM; Assigned to Arm(s): LLM | Intervention Type: OTHER; Name: FFA; Assigned to Arm(s): PTC | Intervention Type: OTHER; Name: Brain Fitness; Assigned to Arm(s): CTC | Intervention Type: OTHER; Name: VideoGrade; Assigned to Arm(s): Active
C: Arm Label: Aerobic exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Group 1, Behavioral: Group 2 | Arm Label: Stretching/toning; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group 3, Behavioral: Group 4 | Arm Label: Computer-based mental activity training; Type: EXPERIMENTAL; Interventions: Behavioral: Group 1, Behavioral: Group 3 | Arm Label: Educational DVD training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group 2, Behavioral: Group 4 | Intervention Type: BEHAVIORAL; Name: Group 1; Assigned to Arm(s): Aerobic exercise, Computer-based mental activity training | Intervention Type: BEHAVIORAL; Name: Group 2; Assigned to Arm(s): Aerobic exercise, Educational DVD training | Intervention Type: BEHAVIORAL; Name: Group 3; Assigned to Arm(s): Computer-based mental activity training, Stretching/toning | Intervention Type: BEHAVIORAL; Name: Group 4; Assigned to Arm(s): Educational DVD training, Stretching/toning
D: Arm Label: cognitive training; Type: EXPERIMENTAL; Interventions: Device: CogniFit Personal Coach® | Intervention Type: DEVICE; Name: CogniFit Personal Coach®; Assigned to Arm(s): cognitive training

Answer: A